Clinical Trials Sponsored by Biotronik France

Total 5806 results

Biotronik France

Unknown

BIOTRONIK - BIOFLOW-III Registry French Satellite

Coronary Artery Diseases

France
Biotronik AG
Biotronik France

Active, not recruiting

BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry (BIOFLOW-VIII)

Myocardial Ischemia | Coronary Artery Disease

France
Biotronik France
Biotronik SE & Co. KG

Completed

Evaluate the Benefits of Pacemaker Follow-Up With Home-Monitoring (COMPAS)

Bradycardia | Pacemaker, Artificial

France
Biotronik France
Biotronik SE & Co. KG

Completed

Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM) (SETAM)

Atrial Fibrillation | Atrial Flutter | Atrial Tachycardia

France
Biotronik France
Biotronik SE & Co. KG

Completed

Observational Study of Patient Comprehension, Perception, Fears and Appreciation Following Home-Monitoring Implementation (Educ@t)

Tachycardia | Defibrillators

France
Biotronik France
MedPass International

Unknown

PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon (PaneLux PTCA)

Coronary Artery Disease | High Bleeding Risk Patients

France
University Hospital, Lille
Biotronik France

Completed

Efficacy, Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy (ECOST-CRT)

Heart Failure | Cardiac Resynchronization Therapy

France
University Hospital, Clermont-Ferrand
LivaNova; Biotronik France

Unknown

Assessment of the Prognosis of Persistent Left Bundle Branch Block (LBBB)After Transcatheter Aortic Valve Implantation (TAVI ) by an Electrophysiological and Remote Monitoring Risk-adapted Algorithm (LBBB-TAVI)

Post-TAVI

France
Biotronik AG
Biotronik, Inc.

Unknown

Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe (BIOFLEX-I EU)

Peripheral Vascular Disease | Peripheral Artery Disease

Germany, Belgium, Austria, Switzerland
Biotronik, Inc.
Biotronik Australia Pty Ltd.; BIOTRONIK Neuro

Recruiting

A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote Management

Chronic Low-back Pain | Chronic Leg Pain

Australia
Biotronik CRC Inc.
Biotronik AG

Active, not recruiting

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Biotronik CRC Inc.
Biotronik AG

Completed

Vascular Implant Safety and Efficacy Study (BIOVITESSE)

Coronary Artery Disease

Switzerland
Biotronik, Inc.

Active, not recruiting

BIOTRONIK Conduction System Pacing With the Solia Lead (BIO-CONDUCT)

Left Bundle-Branch Block | Bradycardia | Cardiomyopathies | Atrioventricular Block

United States
Biotronik AG

Active, not recruiting

Bioflow-DAPT Study

Coronary Artery Disease

Hong Kong, Thailand, France, Latvia, Belgium, Singapore, Switzerland, Spain, New Zealand, Austria, Australia, Malaysia, Denmark, Italy, Germany, Netherlands, Hungary, Poland
Biotronik AG

Completed

BIOLUX P-III SPAIN All-Comers Registry

Peripheral Arterial Disease

Spain
Biotronik AG

Completed

BIOTRONIK 4French for AMBulatory Peripheral Intervention (BIO4AMB)

Peripheral Artery Disease | Access Site Complication | Outpatient Treatment

France, Austria, Belgium, Switzerland
Biotronik, Inc.

Terminated

Protego DF4 Post Approval Registry

Implantable Defibrillator User

United States
Biotronik, Inc.

Terminated

Safety and Performance Study of the Siello S Pacing Lead (SIELLO)

Safety and Effectiveness of the Siello S Lead

United States
Biotronik AG

Unknown

First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) (BIOSOLVE-II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Denmark, Germany, Brazil, Belgium, Netherlands, Singapore, Switzerland
Biotronik, Inc.

Completed

ProMRI ICD/CRT-D Post Approval Study

Tachyarrhythmia
Biotronik AG

Unknown

Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)

Coronary Artery Disease

Latvia, Germany, Spain, Switzerland, Austria, France, Hungary, Netherlands
Biotronik AG

Completed

Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice (ENERGY)

De Novo and Re-stenosed Coronary Artery Lesions

Switzerland, Netherlands, Israel, Spain, Latvia, Germany, Austria, Belgium, France, Ireland
Biotronik, Inc.

Completed

ProMRI Study of the Entovis Pacemaker System (Phase B)

Magnetic Resonance Imaging (MRI); Cardiac Pacing

United States
Biotronik AG

Terminated

The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent (BIOHELIX-II)

Coronary Artery Disease

Netherlands, Switzerland
Biotronik AG

Completed

Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND) (EXPAND)

Severe Intermittent Claudication | Patients With Symptomatic Critical Limb Ischemia

Germany
Biotronik AG

Completed

PROGRESS-AMS 1.0 Clinical Long Term Follow-Up

Long Term Safety of the AMS 1.0

Switzerland, Germany, Australia, Belgium, Netherlands
Biotronik AG

Completed

First in Man Trial - BIOSOLVE-I (BIOSOLVE-I)

de Novo Lesions in Native Coronary Arteries

Netherlands, Switzerland, Germany, Belgium
Biotronik AG

Completed

First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions (BIOFLOW-I)

Coronary Artery Disease

Romania
Biotronik AG

Completed

BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions

Coronary Artery Disease

India
Biotronik AG

Completed

MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study (MULTIBENE)

Coronary Artery Disease
Biotronik, Inc.

Completed

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response (CLEAR)

Bradycardia

United States
Biotronik, Inc.

Completed

Interventricular Delay of Lumax HF-T for Heart Failure

Congestive Heart Failure

Switzerland, United States
Biotronik AG

Recruiting

Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular Procedures (BIO-OSCAR SOC)

Peripheral Arterial Disease

Germany, Belgium, Hungary, Austria, France, Italy, Spain, Switzerland
Biotronik AG

Terminated

BIOFLOW-SV All Comers Registry (BIOFLOW-SV)

Restenoses, Coronary | de Novo | Symptomatic Ischemic Heart Disease

Brazil
Biotronik AG

Terminated

BIOFLOW-SV Portugal Registry (BIOFLOW-SV)

Ischemic Heart Disease

Portugal
Biotronik AG

Active, not recruiting

BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions (BIONETIC-I)

Peripheral Artery Disease

Belgium, Germany, Latvia, Austria, Hungary, France
Biotronik AG

Active, not recruiting

First in Men Study: BIOMAG-I

Coronary Artery Disease

Austria, Spain, Belgium, Poland, Sweden, Germany, Netherlands, Switzerland
Biotronik, Inc.

Active, not recruiting

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-VII)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Ischemic Heart Disease | Atherosclerosis, Coronary

United States
Biotronik AG

Completed

Retrospective Follow-up of BIOLUX P-I/-II

Overall Mortality

Austria, Belgium, Germany
Biotronik, Inc.

Terminated

Plexa ICD Lead Registry

Implantable Defibrillator User

United States
Biotronik AG

Completed

Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III) (BIOSOLVE-III)

Coronary Artery Disease | Coronary Artery Stenosis

Germany, Belgium, Netherlands, Switzerland
Biotronik, Inc.

Completed

Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY) (GALAXY)

Patients Indicated for an ICD

United States
Biotronik, Inc.

Completed

BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment (BioInsight)

Insertable Cardiac Monitor

United States
Biotronik, Inc.

Completed

BIOHELIX-I Bare Metal Stent Study (BIOHELIX-I)

Coronary Arteries Disease

United States, Netherlands, Latvia, Colombia, Germany
Biotronik, Inc.

Terminated

Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace (AVAIL)

Atrial Fibrillation | Congestive Heart Failure

United States
Biotronik, Inc.

Terminated

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk (IMPACT)

Stroke | Atrial Fibrillation | Atrial Flutter | Major Bleeding | Embolism, Systemic Arterial

United States, Canada, United Kingdom, Denmark, Germany, Australia
BIOTRONIK Israel

Completed

BIOFLOW-III Israel Satellite Registry

Myocardial Ischemia | Coronary Artery Disease | Diabetes Mellitus Type 1 or 2

Israel
Biotronik AG

Completed

Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis. (BIOLUX-RCT)

Coronary Artery Disease | Coronary Restenosis

Germany, Latvia
Biotronik AG

Unknown

BIOFLOW-III All-comers Orsiro Safety and Performance Registry (BIOFLOW-III)

Myocardial Ischemia | Coronary Artery Disease

Germany, Latvia, Spain, Netherlands, Italy, Austria, Chile, Denmark, France, Portugal, Sweden, Switzerland, United Kingdom
Biotronik, Inc.

Completed

ProMRI Study of the Iforia ICD System (Phase C)

Implantable Cardioverter-Defibrillator With Magnetic Resonance Imaging

United States

Clinical Trials Sponsored by Biotronik France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations